August 1, 2013, Pennington, NJ – VOX Telehealth, a leader in the development of pro-active, procedure-specific mobile health applications, announced the appointment of its Advisory Board as the company prepares for next phase growth. Representing leaders across the healthcare industry, the board will provide significant depth in knowledge and market strategy in the midst of today’s quickly evolving healthcare environment.

“I have been thrilled by their enthusiasm to serve in this role and participate in the forthcoming phase of our company’s growth,” said Founder and CEO David Brown. “To have the eyes, ears and voice of these recognized leaders will provide tremendous confidence to our management team and incalculable value as we navigate an aggressive strategy for program roll-out, development and market penetration.”

Ken Kaufman – Ken founded Kaufman Hall in 1976 to provide expert counsel and advisory services to healthcare organizations of all types and sizes – including community, academic and national health systems. Having authored or coauthored 6 books and often quoted in major healthcare publications, Ken is a recognized authority and committed educator in the healthcare industry and has given over 400 presentations at major healthcare conferences.

Scott MacLean – As Deputy CIO and Director of IS Operations for Partners Healthcare in Boston, Scott has a long career of healthcare technology implementation at leading healthcare facilities. Seen as an authority regarding the use of technology to support healthcare initiatives, Scott is a regular speaker at HIMSS conference and the Harvard School of Public Health, is a Fellow of the Advisory Board Company and was recognized in 2010 as one of the Top 10 Rising Stars by Healthcare IT News.

Joel Krikston – Joel recently joined Merck Ventures following a successful consulting role for a number of healthcare technology and diagnostics companies. Previously, Joel was a Principal of Venture Investments at Johnson & Johnson Development Corporation (JJDC), leading the group’s efforts in healthcare technology and diagnostics as well as engaging in transactions in biotech and medtech. Prior to joining Johnson & Johnson in 2006, Joel spent 8 years serving a wide range of healthcare clients as an investment banker with BNP Paribas, JPMorgan and ABN Amro.

Daryl Todd – Daryl currently works as Senior Counsel to the Johnson & Johnson companies and specializes in public and private payer reimbursement and innovative payment models. Prior to Johnson & Johnson, Daryl supported public policy strategy at Bristol-Myers Squibb and focused on business formation and reimbursement issues within the healthcare sector for the law firm of McCarter & English.

“Right concept, right time and, now, assembling the right team, we are really excited about the momentum that we are enjoying and know that these individuals, along with some soon to be added, will play a very important role in our future.”